Strive Pharmacy
Tailored compounding for personalized care
Compounding pharmacy offering customized semaglutide and tirzepatide in multiple formulations with third-party quality testing and above-regulation standards.
Medications Available
Pros
- Multiple formulations (injectable, sublingual, oral)
- Third-party quality testing exceeds industry standards
- PCAB and NABP accredited
- Eli Lilly lawsuit DISMISSED October 2025 (wrong jurisdiction; refiled in Arizona)
- Filed antitrust lawsuit against BOTH Eli Lilly and Novo Nordisk (Jan 2026)
- Potency testing variance ±3% (vs industry-accepted ±10%)
- Sterility testing on every single sterile batch
- Recognized as "Specialty Compounding Pharmacy Company of the Year 2025"
Cons
- Compounded medications not FDA-approved
- Requires prescription from external provider
- Pricing not transparent
Compare Strive Pharmacy With
See how Strive Pharmacy stacks up against other providers
About Strive Pharmacy
Strive Compounding Pharmacy offers customized semaglutide and tirzepatide medications in multiple formulations including injectable and sublingual drops. They adhere to state and federal regulations and go above regulatory standards with third-party testing for sterility, potency, and endotoxins.
Formulations Available
- Standard Injectable - Traditional semaglutide/tirzepatide
- Sublingual Drops - Oral sublingual medication
- Semaglutide/B12/Pyridoxine - Vitamin-enhanced oral option
Quality Assurance (Exceeds Industry Standards)
- Potency Testing: Randomized batches tested multiple times weekly (vs. industry standard once yearly)
- Variance Target: ±3% (vs. industry-accepted ±10%)
- Sterility Testing: Every single sterile batch tested for sterility and endotoxins
- Anything less than perfect is discarded
Legal Updates
Eli Lilly lawsuit DISMISSED (Oct 2025) - Federal Judge Stephanos Bibas dismissed for lack of personal jurisdiction (Delaware). However, Lilly refiled in Arizona (Oct 2025) where Strive is headquartered.
Antitrust Countersuit (Jan 14, 2026) - Strive filed an antitrust lawsuit against both Eli Lilly and Novo Nordisk in the Western District of Texas, alleging coordinated suppression of compounded GLP-1 products. Strive argues their “personalized” combinations (tirzepatide + B12 + glycine) are not “essentially copies” of FDA-approved drugs.
Expansion & Recognition
- Breaking ground on Arizona HQ expansion
- Recognized as “Specialty Compounding Pharmacy Company of the Year 2025” by PharmaTech Outlook
How It Works
- Get Prescription - From telehealth or healthcare provider
- Choose Formulation - Injectable, sublingual, or oral
- Quality Compounding - Third-party tested preparation
- Nationwide Shipping - Cold chain delivery
Who Is This Best For?
- Patients wanting third-party tested quality assurance
- Those seeking sublingual or oral options
- People interested in vitamin-enhanced formulations
- Patients whose provider works with Strive
The Bottom Line
Strive Pharmacy’s third-party testing and above-regulation quality standards provide peace of mind. Their multiple formulation options, including sublingual drops, offer flexibility beyond standard injectables.
Last updated: March 2026
Last verified: April 2026
Ready to try Strive Pharmacy?
Compare with other providers or visit their website to get started.